Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONST-PD: Elobixibat for chronic constipation in Parkinson's disease
jRCTs031200172Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Parkinson's disease (PD) and chronic constipation comparing Elobixibat 10 mg with Placebo (2 arms). Started Dec 2020; status: completed.
02
Drugs
elobixibat
03
Conditions
Parkinson's disease (PD)chronic constipation
Beyond the preview
Go deeper on jRCTs031200172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200172.